Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Molecules ; 17(5): 5690-712, 2012 May 11.
Artigo em Inglês | MEDLINE | ID: mdl-22580401

RESUMO

Benzo[c]phenanthridine (BCP) derivatives were identified as topoisomerase I (TOP-I) targeting agents with pronounced antitumor activity. In this study, hologram-QSAR, 2D-QSAR and 3D-QSAR models were developed for BCPs on topoisomerase I inbibitory activity and cytotoxicity against seven tumor cell lines including RPMI8402, CPT-K5, P388, CPT45, KB3-1, KBV-1and KBH5.0. The hologram, 2D, and 3D-QSAR models were obtained with the square of correlation coefficient R² = 0.58-0.77, the square of the crossvalidation coefficient q² = 0.41-0.60 as well as the external set's square of predictive correlation coefficient r² = 0.5-0.80. Moreover, the assessment method based on reliability test with confidence level of 95% was used to validate the predictive power of QSAR models and to prevent over-fitting phenomenon of classical QSAR models. Our QSAR model could be applied to design new analogues of BCPs with higher antitumor and topoisomerase I inhibitory activity.


Assuntos
Antineoplásicos/síntese química , DNA Topoisomerases Tipo I/química , Fenantridinas/síntese química , Relação Quantitativa Estrutura-Atividade , Inibidores da Topoisomerase I/síntese química , Antineoplásicos/farmacologia , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Humanos , Concentração Inibidora 50 , Modelos Químicos , Fenantridinas/farmacologia , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Inibidores da Topoisomerase I/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...